ASLAN Pharmaceuticals Limited announced that Dr. Bertil Lindmark, currently Chief Medical Officer, has announced he will retire and return to Europe. Dr. Chih-Yi Hsieh, currently VP Medical and GM Taiwan, will assume the role of acting Chief Medical Officer. Dr. Mark McHale, Chief Operating Officer, will transition to the role of Chief Development Officer and Head of R&D with immediate effect.